APC and colorectal carcinoma: In Apc mutated CRC cells with intact β-catenin, 1–2 mg/mL mesalazine (corresponding to 6.5–13 mM concentration) increases β-catenin phosphorylation and reduces the expression of Wnt/β-catenin target genes.